|Last Price$12.64||Day Change (%)-0.24%|
|Open Price$12.64||Day Change ($)-0.03|
|Day Range12.64–12.64||52-Week Range12.12–12.80|
As of Thu 10/27/2016 | USD
New Report: Global mAb Biosimilars Market Spending to Grow at a CAGR of 4-7%, 2016-2020 - Key Vendors are Biocon, Celltrion, Dr. Reddy's Laboratories & Hospira - Research and Markets
Overview of Japanese Generic Drug Market 2016 - Research and Markets
Despite the high 39% premium to Hospira's stock price, we believe the acquisition price is justified based on Pfizer's ability to unlock more value with its global reach.
Welcome to Hospira's First Quarter 2014 Conference Call. All lines have been placed on listen-only mode to prevent any background noise. Following the speakers' remarks, there will be a question-and-answer period.
J&J Warns Insulin Pump Vulnerable to Cyber Hacking